Gonyer David A 4
4 · Evoke Pharma Inc · Filed Dec 14, 2020
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Gonyer David A
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2020-12-11$2.90/sh−48,046$139,333→ 363,736 total - Sale
Common Stock
2020-12-14$2.94/sh−23,954$70,425→ 339,782 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.93. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.93 to $2.97. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.